Back

Pleiotropic effects of ticagrelor on microRNA expression in acute coronary syndrome on long term follow up.

28 August 2020 (08:00 - 18:00)
Organised by:
Congress Presentation Part of: Basic Science Cardiac ePosters Biomarkers ESC Premium Access ESC Congress 2020

About the speaker

Photo
Doctor Maria Chiara Grimaldi

Catholic University of the Sacred Heart, Rome (Italy)

110 More presentations in this session

Presentation thumbnail
Elimination of senescent cells targeting Senescence associated glycoprotein (SAGP) improved the ageing-associated diseases and extended the lifespan
Doctor M. Suda (Tokyo, JP)
Abstract Slides
Presentation thumbnail
Single-cell RNA sequencing of human fetal epicardium reveals novel markers and regulators of EMT
Mr T. Streef (Leiden, NL)
Abstract Slides
Presentation thumbnail
Genome-wide association study identifies 18 new susceptibility variants loci associated with Brugada Syndrome
Associate Professor J. Barc (Nantes, FR)
Abstract Slides
Presentation thumbnail
Mutations in CHMP4C cause dilated cardiomyopathy via dysregulation of autophagy
Doctor N. Zhou (Shanghai, CN)
Abstract Slides
Presentation thumbnail
Disruption of the architecture of the junctional sarcoplasmic reticulum in recessive catecholaminergic polymorphic ventricular tachycardia is caused by the er-shaping proteins reep5 and climp63
Doctor R. Bongianino (Pavia, IT)
Abstract Slides

Access the full session

Session thumbnail
Basic Science Cardiac ePosters

The Event

Event poster

ESC Congress 2020

28 August 2020 08:00 CET
You may be interested in
thumbnail
Congress Presentation
MiR-126-3P and MiR-223-3p in Prediction of Thrombotic Risk in Patients with Acute Myocardial Infarction and Primary Angioplasty, The Prague-18 Genetic Sub-study
2 September 2019
thumbnail
Congress Presentation
Pleiotropic effects of inclisiran on arterial structural and functional parameters
4 April 2025
thumbnail
Congress Presentation
Cost-effectiveness of clopidogrel versus ticagrelor in patients of 70 years or older with non-ST-elevation acute coronary syndrome
27 August 2022
thumbnail
Congress Presentation
Platelet inhibitory profiles of prasugrel versus ticagrelor in patients with CYP2C19 loss-of-function genotypes undergoing percutaneous coronary intervention: results of a randomized feasibility study
1 September 2019

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources